Literature DB >> 22527282

Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54).

Manuela O Gustafsson1, Alamdar Hussain, Dara K Mohammad, Abdalla J Mohamed, Vivian Nguyen, Pavel Metalnikov, Karen Colwill, Tony Pawson, C I Edvard Smith, Beston F Nore.   

Abstract

Bruton's tyrosine kinase (Btk), belonging to the Tec family of tyrosine kinases (TFKs), is essential for B-lymphocyte development. Abrogation of Btk signaling causes human X-linked agammaglobulinemia (XLA) and murine X-linked immunodeficiency (Xid). We employed affinity purification of Flag-tagged Btk, combined with tandem mass spectrometry, to capture and identify novel interacting proteins. We here characterize the interaction with ankryin repeat domain 54 protein (ANKRD54), also known as Lyn-interacting ankyrin repeat protein (Liar). While Btk is a nucleocytoplasmic protein, the Liar pool was found to shuttle at a higher rate than Btk. Importantly, our results suggest that Liar mediates nuclear export of both Btk and another TFK, Txk/Rlk. Liar-mediated Btk shuttling was enriched for activation loop, nonphosphorylated Btk and entirely dependent on Btk's SH3 domain. Liar also showed reduced binding to an aspartic acid phosphomimetic SH3 mutant. Three other investigated nucleus-located proteins, Abl, estrogen receptor β (ERβ), and transcription factor T-bet, were all unaffected by Liar. We mapped the interaction site to the C terminus of the Btk SH3 domain. A biotinylated, synthetic Btk peptide, ARDKNGQEGYIPSNYVTEAEDS, was sufficient for this interaction. Liar is the first protein identified that specifically influences the nucleocytoplasmic shuttling of Btk and Txk and belongs to a rare group of known proteins carrying out this activity in a Crm1-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527282      PMCID: PMC3434478          DOI: 10.1128/MCB.06620-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

Review 1.  The IKK complex: an integrator of all signals that activate NF-kappaB?

Authors:  A Israël
Journal:  Trends Cell Biol       Date:  2000-04       Impact factor: 20.808

Review 2.  Signaling--2000 and beyond.

Authors:  T Hunter
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 3.  Tec kinases, actin, and cell adhesion.

Authors:  Julio Gomez-Rodriguez; Julie A Readinger; Irene C Viorritto; Kristen L Mueller; Richard A Houghtling; Pamela L Schwartzberg
Journal:  Immunol Rev       Date:  2007-08       Impact factor: 12.988

Review 4.  Folding landscapes of ankyrin repeat proteins: experiments meet theory.

Authors:  Doug Barrick; Diego U Ferreiro; Elizabeth A Komives
Journal:  Curr Opin Struct Biol       Date:  2008-02       Impact factor: 6.809

5.  Nucleocytoplasmic shuttling of Bruton's tyrosine kinase.

Authors:  A J Mohamed; L Vargas; B F Nore; C M Backesjo; B Christensson; C I Smith
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

6.  Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family GTPases.

Authors:  B F Nore; L Vargas; A J Mohamed; L J Brandén; C M Bäckesjö; T C Islam; P T Mattsson; K Hultenby; B Christensson; C I Smith
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

Review 7.  Role of Txk, a member of the Tec family of tyrosine kinases, in immune-inflammatory diseases.

Authors:  Shoji Mihara; Noboru Suzuki
Journal:  Int Rev Immunol       Date:  2007 Sep-Dec       Impact factor: 5.311

Review 8.  Nuclear trafficking of pro-apoptotic kinases in response to DNA damage.

Authors:  Kiyotsugu Yoshida
Journal:  Trends Mol Med       Date:  2008-06-06       Impact factor: 11.951

9.  Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.

Authors:  Kristina E Halcomb; Sandirai Musuka; Toni Gutierrez; Heather L Wright; Anne B Satterthwaite
Journal:  Mol Immunol       Date:  2008-10-11       Impact factor: 4.407

Review 10.  Phylogeny of Tec family kinases identification of a premetazoan origin of Btk, Bmx, Itk, Tec, Txk, and the Btk regulator SH3BP5.

Authors:  Csaba Ortutay; Beston F Nore; Mauno Vihinen; C I Edvard Smith
Journal:  Adv Genet       Date:  2008       Impact factor: 1.944

View more
  11 in total

1.  Role of Bruton's tyrosine kinase inhibitors in HIV-1-infected cells.

Authors:  Irene Guendel; Sergey Iordanskiy; Gavin C Sampey; Rachel Van Duyne; Valerie Calvert; Emanuel Petricoin; Mohammed Saifuddin; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  J Neurovirol       Date:  2015-02-12       Impact factor: 2.643

2.  Kinomics platform using GBM tissue identifies BTK as being associated with higher patient survival.

Authors:  Sofian Al Shboul; Olimpia E Curran; Javier A Alfaro; Fiona Lickiss; Erisa Nita; Jacek Kowalski; Faris Naji; Rudolf Nenutil; Kathryn L Ball; Radovan Krejcir; Borivoj Vojtesek; Ted R Hupp; Paul M Brennan
Journal:  Life Sci Alliance       Date:  2021-10-13

3.  Palmitoylation of the Alternative Amino Terminus of the BTK-C Isoform Controls Subcellular Distribution and Signaling.

Authors:  Mostafa Kokabee; Xianhui Wang; Elena Voorand; Eden Alin; Leila Kokabee; Faiza Khan; Sophia Desrosiers; Douglas S Conklin
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

4.  Potential effects of CRM1 inhibition in mantle cell lymphoma.

Authors:  Ke-Jie Zhang; Michael Wang
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

5.  Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells.

Authors:  Dara K Mohammad; Beston F Nore; Alamdar Hussain; Manuela O Gustafsson; Abdalla J Mohamed; C I Edvard Smith
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

6.  Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitor.

Authors:  Anna Turetsky; Eunha Kim; Rainer H Kohler; Miles A Miller; Ralph Weissleder
Journal:  Sci Rep       Date:  2014-04-24       Impact factor: 4.379

7.  Control of nuclear-cytoplasmic shuttling of Ankrd54 by PKCδ.

Authors:  Amy L Samuels; Alison Louw; Reza Zareie; Evan Ingley
Journal:  World J Biol Chem       Date:  2017-08-26

8.  ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library.

Authors:  Manuela O Gustafsson; Dara K Mohammad; Erkko Ylösmäki; Hyunseok Choi; Subhash Shrestha; Qing Wang; Beston F Nore; Kalle Saksela; C I Edvard Smith
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

Review 9.  Targeting Bruton's tyrosine kinase in B cell malignancies.

Authors:  Rudi W Hendriks; Saravanan Yuvaraj; Laurens P Kil
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

10.  Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant.

Authors:  A Hamasy; Q Wang; K E M Blomberg; D K Mohammad; L Yu; M Vihinen; A Berglöf; C I E Smith
Journal:  Leukemia       Date:  2016-05-25       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.